PIM kinases were inhibited genetically (using small interfering and short hairpin RNAs) and pharmacologically (mainly with the pan-PIM inhibitor (PIMi) ETP-39010) in a panel of 8 PTCL cell lines. This evidence concerns the gene PIM1 and mature T-cell and NK-cell non-Hodgkin lymphoma.